Prospective Collection of Whole Blood Specimens From RhD Negative Pregnant Women
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexFemale
Age18+
SponsorDevyser Inc.
About this trial
The purpose of this research is to collect blood samples and data from pregnant women who are Rh negative. The blood will be used for the future research and the development of non-invasive prenatal tests to identify Rh blood type status of the baby during pregnancy.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Willing and able to provide written informed consent
18 years of age or older at enrollment
Women with a viable pregnancy (with documented fetal heartbeat) between 12 weeks, 0 days and 28 weeks, 0 days gestational age
Women with RhD negative antigen status by serology
Disqualifiers
None
Trial population
Pregnant women who are RhD negative and between 12 and 28 weeks gestation.
Trial design
Design model
Cohort
Time perspective
Prospective
Treatments tested in this trial
Not listed
Trial groups
500 Participants
are grouped into 1 trial groupGroup A: Pregnant women
Trial outcomes
Primary outcomes
1
Fetal RhD determination from maternal whole blood
Collected samples will be used for future development of non-invasive prenatal test to determine fetal RhD status from maternal whole blood
Time frame
18 monthsSponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov